MEFV and hepatocellular carcinoma: Hepatocellular carcinoma, Radiotherapy, Autophagy, Immunomodulation, Sars-cov-2, Adjuvant, Vaccine, Antigen delivery, Innate immune response, Inflammasome, Mucosal adjuvant, Mucosal vaccine, BCG, Gut microbiome, NOD-like receptor with pyrin domain (Nalt), Trypanosoma cruzi, Trans-sialidase, Dec-205, Subcutaneous route, Archaeosomems, HCV, STING agonist